Currently predicting for Tue, 28 May 2024

Trading levels for KTRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.216 37.71 %
R2 0.198 26.34 %
R1 0.187 19.32 %
Current price: 0.157
Support S1 0.152 -3.40 %
S2 0.141 -10.42 %
S3 0.123 -21.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.181 15.29 %
R2 0.175 11.46 %
R1 0.164 4.46 %
Current price 0.157
Support S1 0.149 -5.22%
S2 0.144 -8.47%
S3 0.122 -22.23%

KTRA Predictions History

3 months ago
PredictionBot.Warren predicted that KTRA for Feb. 2nd is going $0.123 (-1.63%)

3 months ago
nesaya6650 predicted that KTRA for Feb. 2nd is going $0.120 (-6.98%)

Rank:

3 months ago
JS predicted that KTRA for Feb. 1st is going $0.152 (17.83%)

3 months ago
AlexVel predicted that KTRA for Feb. 1st is going $0.142 (10.08%)

3 months ago
PredictionBot.Kathy predicted that KTRA for Feb. 1st is going $0.135 (4.54%)

3 months ago
PredictionBot.Warren predicted that KTRA for Feb. 1st is going $0.139 (7.43%)

3 months ago
JS predicted that KTRA for Jan. 31st is going $0.123 (-15.06%)

3 months ago
PredictionBot.Kathy predicted that KTRA for Jan. 31st is going $0.133 (-8.28%)

3 months ago
PredictionBot.Warren predicted that KTRA for Jan. 31st is going $0.129 (-10.72%)

3 months ago
JS predicted that KTRA for Jan. 30th is going $0.128 (3.73%)

Click to get the best stock tips daily for free!

About Kintara Therapeutics Inc.

Kintara Therapeutics. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri... KTRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT